FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/08/035488 [Registered on: 06/08/2021] Trial Registered Prospectively
Last Modified On: 30/08/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Other 
Public Title of Study   Nelli Mulli Ilagam in the treatmentof Iron Deficiency Anaemia 
Scientific Title of Study   CLINICAL EVALUATION OF SIDDHA HERBAL FORMULATION NELLI MULLI ILAGAM IN THE TREATMENT OF PITHA PAANDU (IRON DEFICIENCY ANAEMIA) 
Trial Acronym  CLINICAL STUDY 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Chithra MG 
Designation  PG Scholar 
Affiliation  National Institute of Siddha 
Address  Room No 1, Department of Maruthuvam, National Institute of Siddha, Tambaram Sanatorium, Chennai Kancheepuram TAMIL NADU 600047 India
Room No 1, Department of Maruthuvam, National Institute of Siddha, Tambaram Sanatorium, Chennai Kancheepuram TAMIL NADU 600047 India
Kancheepuram
TAMIL NADU
Dr Chithra M G
India 
Phone  9677551634  
Fax  22381314  
Email  chithramanibsms@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrT LAKSHMI KANTHAM MDS PhD 
Designation  Associate Professor 
Affiliation  National Institute of Siddha 
Address  Room no 1,Department of Maruthuvam, National Institute of Siddha , Tambaram Sanatorium
Room no 1,Department of Maruthuvam, National Institute of Siddha , Tambaram Sanatorium
Kancheepuram
TAMIL NADU
600047
India 
Phone  9025575185  
Fax  22381314  
Email  drlakshmiramaswamy@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrMGCHITHRA 
Designation  PG Scholar 
Affiliation  National Institute of Siddha 
Address  Room no 1, Department of Maruthuvam,National Institute of Siddha,Tambaram Sanatorium.
Room no 1, Department of Maruthuvam,National Institute of Siddha,Tambaram Sanatorium.
Kancheepuram
TAMIL NADU
600047
India 
Phone  9677551634  
Fax  22381314  
Email  chithramanibsms@gmail.com  
 
Source of Monetary or Material Support  
DEPARTMENT OF MARUTHUVAM,AYOTHIDOSS PANDITHAR HOSPITAL,NATIONAL INSTITUTE OF SIDDHA,TAMBARAM SANATORIUM,CHENNAI - 600047  
 
Primary Sponsor  
Name  National Institute of Siddha 
Address  ROOM NO 1, DEPARTMENT OF MARUTHUVAM,AYOTHIDOSS PANDITHAR HOSPITAL,NATIONAL INSTITUTE OF SIDDHA,TAMBARAM SANATORIUM, CHENNAI - 600047 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrMGChithra  AYOTHIDOSS PANDITHAR HOSPITAL  Room no 1, Department of Maruthuvam,National Institute of Siddha,Tambaram Sanatorium.
Kancheepuram
TAMIL NADU 
9677551634
22381314
chithramanibsms@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institutional Ethical Committee  Submittted/Under Review 
Institutional Ethical Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  , (1) ICD-10 Condition: D509||Iron deficiency anemia, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nelli Mulli Ilagam  Nelli Mulli Ilagam in the treatment of Pitha paandu Dosage : 8 gram twice a day Days: 48 days  
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  14.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients with appropriate symptoms like pallor of skin, excessive of thirst, fatigue, blurred vision, giddiness, chest tightness, breathlessness, pungent or bitter taste, angular stomatitis, glossitis, cheilosis
Hb level less than normal range,
For male: 9-11gms/d1
For female: 8-10gms /dl
Abnormal peripheral smear study – Microcytic Hypochromic Anaemia
Patient willing to undergo blood investigation.

 
 
ExclusionCriteria 
Details  Presence of any associated severe systemic illness like cancer, AIDS
Chronic Kidney Disease
Diabetes Mellitus
Pregnant women
Inherited defects like Sickle cell anaemia, Thalassemia, Aplastic anaemia
Patients not willing to give blood sample  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Primary outcome will be assessed by comparing the pre and post treatment status of Peripheral smear and Haemoglobin level of the study subjects.  1 year 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction of clinical symptoms
Improvement in complete blood count
Siddha basic principles like Envagai thervu, Neerkuri neikuri, Udal thaathukal in pitha paandu patients
The cofactors such as socioeconomic status, occupation, dietary habits, chronic blood loss conditions will be studied 
Fourty ninth day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "30"
Final Enrollment numbers achieved (India)="30" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   12/08/2021 
Date of Study Completion (India) 24/01/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="1"
Days="18" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
It is an interventional study in which 30 patients with any of the symptoms like pallor of skin, excessive thirst, giddiness, chest tightness, breathlessness, pungent or bitter taste, angular stomatitis, glossitis, fatigue will be selected based on inclusion and exclusion criteria. After enrolling the patients in the study, Nelli mulli ilgam 8 gram will be given twice a day for 48 days. After 48 days, patients will be asked to do blood investigations for any changes in it and absence of clinical signs and symptoms of Pitha paandu. 
Close